STAT+: Most-favored nations policy makes drugmakers rethink launches abroad

Spread the love



Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Thanksgiving is approaching and I’ve yet to make an all-butter pie crust that doesn’t shrink. Any tips or suggestions appreciated!

Ex-employee says Lilly promoted GLP-1 drug off-label

A former Eli Lilly sales rep filed a lawsuit alleging that she was fired after complaining that the company promoted its Mounjaro diabetes drug as a weight loss treatment before receiving regulatory approval to do so.

Continue to STAT+ to read the full story…



Source link

By admin